Measuring the Effect of Radiation Therapy on Patient Activity Levels
NCT ID: NCT02694380
Last Updated: 2018-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
32 participants
OBSERVATIONAL
2015-07-31
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer
NCT02649569
Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation
NCT02189967
Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
NCT00776100
An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPMā¢) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System
NCT02067858
Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer
NCT03035890
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Head and Neck
Subjects with head and neck cancer receiving radiation therapy.
No interventions assigned to this group
Prostate
Subjects with prostate cancer receiving radiation therapy.
No interventions assigned to this group
Breast
Subjects with breast cancer receiving radiation therapy.
No interventions assigned to this group
Lung
Subjects with lung cancer receiving radiation therapy.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eastern Cooperative Oncology Group (ECOG) performance status of 0-1
* Ability to walk 100 feet without rest
* Signed informed consent
Exclusion Criteria
* Known metastatic disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pittsburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Colin E. Champ, MD
Assistant Clinical Professor University of Pittsburgh Radiation Oncology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Colin Champ, MD
Role: PRINCIPAL_INVESTIGATOR
UPMC Department of Radiation Oncology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UPMC St. Margaret Department of Radiation Oncology
Pittsburgh, Pennsylvania, United States
UPMC Shadyside Department of Radiation Oncology
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-160
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.